Translate Bio, Inc. Common Stock
TBIO
TBIO was delisted on the 13th of September, 2021.
67 hedge funds and large institutions have $521M invested in Translate Bio, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 28 increasing their positions, 7 reducing their positions, and 9 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 7
78% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 9
12% more capital invested
Capital invested by funds: $466M → $521M (+$55.1M)
12% more funds holding
Funds holding: 60 → 67 (+7)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
+$82.1M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$14.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$12.2M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$8.66M |
| 5 |
Citigroup
New York
|
+$7.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Highbridge Capital Management
New York
|
-$1.32M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$1M |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$852K |
| 4 |
FI
Fosun International
Hong Kong,
China
|
-$780K |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$490K |
TBIO Hedge Fund Activity: Q3 2019 in Review
67 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q3 2019, worth a combined $521M — up 12% from $466M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new TBIO positions and 9 closed out — a net gain of 7 holders — while 28 added to existing stakes and 7 trimmed.
The largest buyer was Baupost Group, adding an estimated $82.1M. The largest seller was Highbridge Capital Management, cutting an estimated $1.32M.
- 67 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q3 2019, up from 60 in Q2 2019.
- Funds reported $521M of Translate Bio, Inc. Common Stock stock for Q3 2019, up 12% quarter-over-quarter.
- 16 funds opened new Translate Bio, Inc. Common Stock positions in Q3 2019 and 9 closed out, a net change of +7 holders.
- The largest Translate Bio, Inc. Common Stock buyer in Q3 2019 was Baupost Group, an estimated $82.1M added.
- The largest Translate Bio, Inc. Common Stock seller in Q3 2019 was Highbridge Capital Management, an estimated $1.32M sold.
Based on aggregated 13F filings for Q3 2019.